Changes in Extracellular Levels of Glutamate and Aspartate in Rat Substantia Nigra Induced by Dopamine Receptor Ligands: in Vivo Microdialysis Studies

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 1995 Feb 1

PMID 7783840

Citations 8

Authors

J Abarca

K Gysling

R H Roth

G Bustos

Affiliations

Soon will be listed here.

Abstract

The microdialysis technique was utilized to study the local effects of D1 and D2 family type dopamine (DA) receptor (R) ligands on the in vivo release of endogenous glutamate (GLU) and aspartate (ASP) from rat substantia nigra (SN). Addition to the dialysis perfusion solution of either D1-R and D2-R agonists, such as SKF-38393 (50 and 100 microM) and Quinpirole (5 and 10 microM), resulted in dose-dependent increases in extracellular concentrations of GLU and ASP, respectively. The SKF-38393 and Quinpirole-induced effects were reduced by SCH-23390 (0.5 microM), a D1-R antagonist, and by Spiperone (1.0 microM), a D2-R antagonist, respectively. However, SCH-23390 and Spiperone did increase GLU and ASP extracellular concentrations. Local infusion with Tetrodotoxin (TTX) (1.0 microM), a blocker of voltage-dependent Na+ channels, increased basal extracellular levels of GLU. In addition, co-infusion of TTX and SKF-38393 evoked increases in extracellular GLU levels higher than those observed after SKF-38393 alone. Finally, chemical lesions of nigral DA cells with 6-OH-DA increased the basal extracellular levels of GLU. It is proposed that the release of GLU and ASP from SN may be regulated by D1- and D2-receptors present in this basal ganglia structure. In addition, part of the D1 receptors present in SN might be located presynaptically on GLU-containing nerve endings.

Citing Articles

Transient receptor potential ankyrin 1 channel modulates the abuse-related mechanisms of methamphetamine through interaction with dopamine transporter.

Hur K, Lee Y, Donio A, Kim S, Lee B, Seo J Br J Pharmacol. 2024; 181(16):2794-2809.

PMID: 38644533 PMC: 11230846. DOI: 10.1111/bph.16370.

Increased Fear Memory and Glutamatergic Modulation in Compulsive Drinker Rats Selected by Schedule-Induced Polydipsia.

Prados-Pardo A, Martin-Gonzalez E, Mora S, Merchan A, Flores P, Moreno M Front Behav Neurosci. 2019; 13:100.

PMID: 31133835 PMC: 6514533. DOI: 10.3389/fnbeh.2019.00100.

High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson's disease.

Favier M, Carcenac C, Drui G, Boulet S, El Mestikawy S, Savasta M BMC Neurosci. 2013; 14:152.

PMID: 24308494 PMC: 4234365. DOI: 10.1186/1471-2202-14-152.

Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.

Ghiglieri V, Bagetta V, Pendolino V, Picconi B, Calabresi P Parkinsons Dis. 2012; 2012:358176.

PMID: 22666628 PMC: 3359773. DOI: 10.1155/2012/358176.

Ethanol enhances glutamate transmission by retrograde dopamine signaling in a postsynaptic neuron/synaptic bouton preparation from the ventral tegmental area.

Deng C, Li K, Zhou C, Ye J Neuropsychopharmacology. 2008; 34(5):1233-44.

PMID: 18784647 PMC: 2761034. DOI: 10.1038/npp.2008.143.

References

Klockgether T, Turski L . Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci. 1989; 12(8):285-6. DOI: 10.1016/0166-2236(89)90007-6. View

Gale K . Progression and generalization of seizure discharge: anatomical and neurochemical substrates. Epilepsia. 1988; 29 Suppl 2:S15-34. DOI: 10.1111/j.1528-1157.1988.tb05795.x. View

Waddington J . Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems. Biochem Pharmacol. 1986; 35(21):3661-7. DOI: 10.1016/0006-2952(86)90649-0. View

Weiner D, Levey A, Sunahara R, Niznik H, ODowd B, Seeman P . D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A. 1991; 88(5):1859-63. PMC: 51125. DOI: 10.1073/pnas.88.5.1859. View

Kornhuber J, Kim J, Kornhuber M, Kornhuber H . The cortico-nigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res. 1984; 322(1):124-6. DOI: 10.1016/0006-8993(84)91189-2. View

Jacobson I, Hamberger A . Kainic acid-induced changes of extracellular amino acid levels, evoked potentials and EEG activity in the rabbit olfactory bulb. Brain Res. 1985; 348(2):289-96. DOI: 10.1016/0006-8993(85)90447-0. View

Lehmann A, Isacsson H, Hamberger A . Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J Neurochem. 1983; 40(5):1314-20. DOI: 10.1111/j.1471-4159.1983.tb13572.x. View

Quik M, Iversen L . Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain. Eur J Pharmacol. 1979; 56(4):323-30. DOI: 10.1016/0014-2999(79)90262-0. View

Hollerman J, Grace A . The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res. 1990; 533(2):203-12. DOI: 10.1016/0006-8993(90)91341-d. View

10.

Aghajanian G, Bunney B . Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol. 1977; 297(1):1-7. DOI: 10.1007/BF00508803. View

11.

Nicholls D . Release of glutamate, aspartate, and gamma-aminobutyric acid from isolated nerve terminals. J Neurochem. 1989; 52(2):331-41. DOI: 10.1111/j.1471-4159.1989.tb09126.x. View

12.

Nagahama S, Chen Y, Lindheimer M, Oparil S . Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat. J Pharmacol Exp Ther. 1986; 236(3):735-42. View

13.

Dubois A, Savasta M, Curet O, Scatton B . Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience. 1986; 19(1):125-37. DOI: 10.1016/0306-4522(86)90010-2. View

14.

Wilkinson R, Nicholls D . Compartmentation of glutamate and aspartate within cerebral cortical synaptosomes: evidence for a non-cytoplasmic origin for the calcium-releasable pool of glutamate. Neurochem Int. 2010; 15(2):191-7. DOI: 10.1016/0197-0186(89)90100-9. View

15.

Quik M, Emson P, Joyce E . Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra. Brain Res. 1979; 167(2):355-65. DOI: 10.1016/0006-8993(79)90829-1. View

16.

Grace A, Bunney B . Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization. Neuroscience. 1983; 10(2):301-15. DOI: 10.1016/0306-4522(83)90135-5. View

17.

Albin R, Young A, Penney J . The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989; 12(10):366-75. DOI: 10.1016/0166-2236(89)90074-x. View

18.

Fiedler J, Bustos G . Cortical ablation reduces veratridine evoked release of endogenous glutamate from superfused substantia nigra slices. Neurosci Lett. 1991; 122(1):96-8. DOI: 10.1016/0304-3940(91)90202-5. View

19.

Porceddu M, Giorgi O, Ongini E, Mele S, Biggio G . 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine. Life Sci. 1986; 39(4):321-8. DOI: 10.1016/0024-3205(86)90650-8. View

20.

Weick B, Engber T, Susel Z, Chase T, Walters J . Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration. Brain Res. 1990; 523(1):16-22. DOI: 10.1016/0006-8993(90)91631-p. View